The novel therapy of this peptide represents a major breakthrough in the handling of type 2 diabetes. Different to existing medications, tirzepatide impacts dual pathways – glucagon-like peptide-1 (GLP-1) and GIP – https://tirzepatidepeptide059110.daneblogger.com/40649028/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment